COVID-19 Impact on Global Motion Sickness Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: CE3CE019EF81EN
QYResearch

Abstracts

This report focuses on the global Motion Sickness Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Motion Sickness Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Baxter International Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson Services Inc.
• Pfizer Inc.
• Prestige Consumer Healthcare Inc.
• ...

Market segment by Type, the product can be split into

• Anticholinergics
• Antihistamines

Market segment by Application, split into

• Hospital
• Research institute
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Motion Sickness Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Motion Sickness Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Motion Sickness Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Motion Sickness Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Motion Sickness Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Anticholinergics
  1.4.3 Antihistamines
1.5 Market by Application
  1.5.1 Global Motion Sickness Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Research institute
  1.5.4 Clinic
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Motion Sickness Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Motion Sickness Drugs Industry
    1.6.1.1 Motion Sickness Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Motion Sickness Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Motion Sickness Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Motion Sickness Drugs Market Perspective (2015-2026)
2.2 Motion Sickness Drugs Growth Trends by Regions
  2.2.1 Motion Sickness Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Motion Sickness Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Motion Sickness Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Motion Sickness Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Motion Sickness Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Motion Sickness Drugs Players by Market Size
  3.1.1 Global Top Motion Sickness Drugs Players by Revenue (2015-2020)
  3.1.2 Global Motion Sickness Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Motion Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Motion Sickness Drugs Market Concentration Ratio
  3.2.1 Global Motion Sickness Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Motion Sickness Drugs Revenue in 2019
3.3 Motion Sickness Drugs Key Players Head office and Area Served
3.4 Key Players Motion Sickness Drugs Product Solution and Service
3.5 Date of Enter into Motion Sickness Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Motion Sickness Drugs Historic Market Size by Type (2015-2020)
4.2 Global Motion Sickness Drugs Forecasted Market Size by Type (2021-2026)

5 MOTION SICKNESS DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Motion Sickness Drugs Market Size by Application (2015-2020)
5.2 Global Motion Sickness Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Motion Sickness Drugs Market Size (2015-2020)
6.2 Motion Sickness Drugs Key Players in North America (2019-2020)
6.3 North America Motion Sickness Drugs Market Size by Type (2015-2020)
6.4 North America Motion Sickness Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Motion Sickness Drugs Market Size (2015-2020)
7.2 Motion Sickness Drugs Key Players in Europe (2019-2020)
7.3 Europe Motion Sickness Drugs Market Size by Type (2015-2020)
7.4 Europe Motion Sickness Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Motion Sickness Drugs Market Size (2015-2020)
8.2 Motion Sickness Drugs Key Players in China (2019-2020)
8.3 China Motion Sickness Drugs Market Size by Type (2015-2020)
8.4 China Motion Sickness Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Motion Sickness Drugs Market Size (2015-2020)
9.2 Motion Sickness Drugs Key Players in Japan (2019-2020)
9.3 Japan Motion Sickness Drugs Market Size by Type (2015-2020)
9.4 Japan Motion Sickness Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Motion Sickness Drugs Market Size (2015-2020)
10.2 Motion Sickness Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Motion Sickness Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Motion Sickness Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Motion Sickness Drugs Market Size (2015-2020)
11.2 Motion Sickness Drugs Key Players in India (2019-2020)
11.3 India Motion Sickness Drugs Market Size by Type (2015-2020)
11.4 India Motion Sickness Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Motion Sickness Drugs Market Size (2015-2020)
12.2 Motion Sickness Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Motion Sickness Drugs Market Size by Type (2015-2020)
12.4 Central & South America Motion Sickness Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Baxter International Inc.
  13.1.1 Baxter International Inc. Company Details
  13.1.2 Baxter International Inc. Business Overview and Its Total Revenue
  13.1.3 Baxter International Inc. Motion Sickness Drugs Introduction
  13.1.4 Baxter International Inc. Revenue in Motion Sickness Drugs Business (2015-2020))
  13.1.5 Baxter International Inc. Recent Development
13.2 GlaxoSmithKline Plc
  13.2.1 GlaxoSmithKline Plc Company Details
  13.2.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Plc Motion Sickness Drugs Introduction
  13.2.4 GlaxoSmithKline Plc Revenue in Motion Sickness Drugs Business (2015-2020)
  13.2.5 GlaxoSmithKline Plc Recent Development
13.3 Johnson & Johnson Services Inc.
  13.3.1 Johnson & Johnson Services Inc. Company Details
  13.3.2 Johnson & Johnson Services Inc. Business Overview and Its Total Revenue
  13.3.3 Johnson & Johnson Services Inc. Motion Sickness Drugs Introduction
  13.3.4 Johnson & Johnson Services Inc. Revenue in Motion Sickness Drugs Business (2015-2020)
  13.3.5 Johnson & Johnson Services Inc. Recent Development
13.4 Pfizer Inc.
  13.4.1 Pfizer Inc. Company Details
  13.4.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.4.3 Pfizer Inc. Motion Sickness Drugs Introduction
  13.4.4 Pfizer Inc. Revenue in Motion Sickness Drugs Business (2015-2020)
  13.4.5 Pfizer Inc. Recent Development
13.5 Prestige Consumer Healthcare Inc.
  13.5.1 Prestige Consumer Healthcare Inc. Company Details
  13.5.2 Prestige Consumer Healthcare Inc. Business Overview and Its Total Revenue
  13.5.3 Prestige Consumer Healthcare Inc. Motion Sickness Drugs Introduction
  13.5.4 Prestige Consumer Healthcare Inc. Revenue in Motion Sickness Drugs Business (2015-2020)
  13.5.5 Prestige Consumer Healthcare Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Motion Sickness Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Motion Sickness Drugs Revenue
Table 3. Ranking of Global Top Motion Sickness Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Motion Sickness Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticholinergics
Table 6. Key Players of Antihistamines
Table 7. COVID-19 Impact Global Market: (Four Motion Sickness Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Motion Sickness Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Motion Sickness Drugs Players to Combat Covid-19 Impact
Table 12. Global Motion Sickness Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Motion Sickness Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Motion Sickness Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Motion Sickness Drugs Market Share by Regions (2015-2020)
Table 16. Global Motion Sickness Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Motion Sickness Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Motion Sickness Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Motion Sickness Drugs Players
Table 23. Global Motion Sickness Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Motion Sickness Drugs Market Share by Players (2015-2020)
Table 25. Global Top Motion Sickness Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motion Sickness Drugs as of 2019)
Table 26. Global Motion Sickness Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Motion Sickness Drugs Product Solution and Service
Table 29. Date of Enter into Motion Sickness Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Motion Sickness Drugs Market Size Share by Type (2015-2020)
Table 33. Global Motion Sickness Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Motion Sickness Drugs Market Size Share by Application (2015-2020)
Table 35. Global Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Motion Sickness Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Motion Sickness Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Motion Sickness Drugs Market Share (2019-2020)
Table 39. North America Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Motion Sickness Drugs Market Share by Type (2015-2020)
Table 41. North America Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Motion Sickness Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Motion Sickness Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Motion Sickness Drugs Market Share (2019-2020)
Table 45. Europe Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Motion Sickness Drugs Market Share by Type (2015-2020)
Table 47. Europe Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Motion Sickness Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Motion Sickness Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Motion Sickness Drugs Market Share (2019-2020)
Table 51. China Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Motion Sickness Drugs Market Share by Type (2015-2020)
Table 53. China Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Motion Sickness Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Motion Sickness Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Motion Sickness Drugs Market Share (2019-2020)
Table 57. Japan Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Motion Sickness Drugs Market Share by Type (2015-2020)
Table 59. Japan Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Motion Sickness Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Motion Sickness Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Motion Sickness Drugs Market Share (2019-2020)
Table 63. Southeast Asia Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Motion Sickness Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Motion Sickness Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Motion Sickness Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Motion Sickness Drugs Market Share (2019-2020)
Table 69. India Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Motion Sickness Drugs Market Share by Type (2015-2020)
Table 71. India Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Motion Sickness Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Motion Sickness Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Motion Sickness Drugs Market Share (2019-2020)
Table 75. Central & South America Motion Sickness Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Motion Sickness Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Motion Sickness Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Motion Sickness Drugs Market Share by Application (2015-2020)
Table 79. Baxter International Inc. Company Details
Table 80. Baxter International Inc. Business Overview
Table 81. Baxter International Inc. Product
Table 82. Baxter International Inc. Revenue in Motion Sickness Drugs Business (2015-2020) (Million US$)
Table 83. Baxter International Inc. Recent Development
Table 84. GlaxoSmithKline Plc Company Details
Table 85. GlaxoSmithKline Plc Business Overview
Table 86. GlaxoSmithKline Plc Product
Table 87. GlaxoSmithKline Plc Revenue in Motion Sickness Drugs Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Plc Recent Development
Table 89. Johnson & Johnson Services Inc. Company Details
Table 90. Johnson & Johnson Services Inc. Business Overview
Table 91. Johnson & Johnson Services Inc. Product
Table 92. Johnson & Johnson Services Inc. Revenue in Motion Sickness Drugs Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Services Inc. Recent Development
Table 94. Pfizer Inc. Company Details
Table 95. Pfizer Inc. Business Overview
Table 96. Pfizer Inc. Product
Table 97. Pfizer Inc. Revenue in Motion Sickness Drugs Business (2015-2020) (Million US$)
Table 98. Pfizer Inc. Recent Development
Table 99. Prestige Consumer Healthcare Inc. Company Details
Table 100. Prestige Consumer Healthcare Inc. Business Overview
Table 101. Prestige Consumer Healthcare Inc. Product
Table 102. Prestige Consumer Healthcare Inc. Revenue in Motion Sickness Drugs Business (2015-2020) (Million US$)
Table 103. Prestige Consumer Healthcare Inc. Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Motion Sickness Drugs Market Share by Type: 2020 VS 2026
Figure 2. Anticholinergics Features
Figure 3. Antihistamines Features
Figure 4. Global Motion Sickness Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Research institute Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Motion Sickness Drugs Report Years Considered
Figure 10. Global Motion Sickness Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Motion Sickness Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Motion Sickness Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Motion Sickness Drugs Market Share by Players in 2019
Figure 15. Global Top Motion Sickness Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motion Sickness Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Motion Sickness Drugs Revenue in 2019
Figure 17. North America Motion Sickness Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Motion Sickness Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Motion Sickness Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Motion Sickness Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Motion Sickness Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Motion Sickness Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Motion Sickness Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Baxter International Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Baxter International Inc. Revenue Growth Rate in Motion Sickness Drugs Business (2015-2020)
Figure 26. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. GlaxoSmithKline Plc Revenue Growth Rate in Motion Sickness Drugs Business (2015-2020)
Figure 28. Johnson & Johnson Services Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Johnson & Johnson Services Inc. Revenue Growth Rate in Motion Sickness Drugs Business (2015-2020)
Figure 30. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pfizer Inc. Revenue Growth Rate in Motion Sickness Drugs Business (2015-2020)
Figure 32. Prestige Consumer Healthcare Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Prestige Consumer Healthcare Inc. Revenue Growth Rate in Motion Sickness Drugs Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed